Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study
- 9 May 2022
- journal article
- research article
- Published by BMJ in Frontline Gastroenterology
- Vol. 14 (1) , 19-24
Abstract
Objective Hepatocellular carcinoma (HCC) is increasingly incident in England, while survival remains poor with regional disparities. We aimed to explore the differences in HCC treatment across different geographical regions and to examine the impact on cancer survival. Methods Incident HCC cases and treatment were identified from the English Hospital Episode Statistics (2016–2017) and then a subset by National Health Service (NHS) regions. Treatment was grouped into curative, palliative and untreated. Median survival was estimated to date of death in the national statistics. Results The median observed survival was 8.6 months (95% CI 7.5 to 9.9) across all 2160 HCC cases, 52.1 months (CI 50.5, not reached) in 449 (20.8%) treated with curative intent, 21.0 months (CI 18.5 to 24.5) after other cancer-specific treatment in 449 (20.8%), and 2.3 months (CI 2.1 to 2.6) in 1262 (58.4%) untreated. Across NHS regions, Conclusion Majority of HCC cases in England are untreated and survival remains low, with variation in outcomes in regions with similar incident rates. A deeper exploration of regional treatments and screening practice is required to improve early detection and survival.Keywords
Funding Information
- Bristol-Myers Squibb (Not applicable)
This publication has 13 references indexed in Scilit:
- Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United KingdomEpidemiology, 2018
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United KingdomEpidemiology, 2018
- Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western countryJournal of Hepatology, 2017
- Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillanceBritish Journal of Cancer, 2017
- A national survey of the provision of ultrasound surveillance for the detection of hepatocellular carcinomaFrontline Gastroenterology, 2015
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysisPLOS Medicine, 2014
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menaceJournal of Hepatology, 2012
- A Comparison of Prognosis between Patients with Hepatitis B and C Virus‐related Hepatocellular Carcinoma Undergoing Resection SurgeryWorld Journal of Surgery, 2011
- Epidemiology, risk factors and surveillance of hepatocellular carcinoma.2010